|
|
 |
Help shape ESCMID’s future
|
|
There are a number of open positions in our ESCMID Subcommittees. Interested and qualified members should review the open positions and apply before the deadline. Bring your big ideas to ESCMID and help make our society better for our members and beyond.
|
|
|
| |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Science & Research
|
 |
Immunisation readiness: lessons learned from ebola
|
|
The second part of the Bundibugyo ebolavirus vaccine series took place last week and is now available for replay on ESCMID Media for those that missed the live event. Be sure to also register for the last part taking place 14 October covering the immunisation readiness and vaccination strategies.
|
|
|
|
|
| |
Education
|
 |
Managing classical and emerging hepatitis viruses
|
|
Explore the clinical and public health management of classical and emerging hepatitis viruses, including hepatitis A–E and viral haemorrhagic fevers such as yellow fever, dengue, and Crimean-Congo haemorrhagic fever. Persons interested in viral liver diseases will not want to miss this.
|
|
|
| |
 |
The ins and outs of clinical trials
|
|
This introductory to intermediate course is designed to give clinicians, trainees and researchers hands-on experience in designing, running and analysing clinical trials, the gold standard for generating high-quality clinical evidence in infectious diseases and clinical microbiology.
|
|
|
| |
Congress & Events
|
 |
ESCMID Global 2027 abstract submissions open tomorrow
|
|
Starting tomorrow, we will begin accepting abstract submissions for the next edition of the ESCMID Global congress taking place in Stockholm, Sweden in April 2027. Submissions will be open until 18 November so be sure to visit the website and learn more.
|
|
|
| |
Guidelines & Journals
|
 |
Listen to the latest Communicable episode!
|
|
Hosts Emily McDonald and Marc Bonten are joined by Sylvain Lother and Valentijn Schweitzer for a discussion on the use of macrolides in community-acquired pneumonia. They examine the evidence for adding a macrolide to beta-lactam therapy, and how available evidence can inform clinical practice.
|
|
|
| |
 |
Epi Alert: 06 October 2026
|
|
The Bundibugyo virus disease outbreak in the Democratic Republic of the Congo continues to expand, reaching 8,442 confirmed cases and 4,080 deaths, with international medical evacuations to the Netherlands and Germany underscoring the risk of cross-border spread. In Europe, autochthonous chikungunya transmission in France has increased to 124 cases, while Germany has reported its first confirmed symptomatic autochthonous human Sindbis virus infection. West Nile virus transmission remains widespread across 16 European countries, with 1,765 locally acquired cases reported this season. Thailand is experiencing an elevated leptospirosis season amid flooding, recording 3,303 cases. Elsewhere, a possible fatal laboratory-acquired pneumonic plague case in the Russian Federation has prompted the hospitalisation of 197 contacts, and Zambia has declared a cholera outbreak involving 304 suspected cases.
|
|
|
| |
|
|
|
|
|
In vitro activity of rezafungin against bloodstream and intra-abdominal Candida isolates: a large EUCAST-based studys
|
|
|
|
|
|
Protocol for the National Data Stream-IICU: a multicentre Swiss platform integrating multimodal clinical and pathogen data for personalised prediction of infection-related outcomes in intensive care
|
| |
|
|